Animal Hormone Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Global Animal Hormone Therapy Market is Segmented by Application (Growth Promotors, Performance Enhancers, and Other Applications), Animals (Companion Animals and Livestock), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Animal Hormone Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Animal Hormone Therapy Industry Overview

The animal hormone therapy market is highly competitive, with several players across the world. In terms of market share, major players currently dominate the market. With the increasing burden of diseases and technological advancement in animal healthcare, many new players are expected to be part of the market over the forecast period. Some of the major players are Merck & Co. Inc., Boehringer Ingelheim, Elanco Inc., Virbac Group, and Vetoquinol SA.

Animal Hormone Therapy Market Leaders

  1. Boehringer Ingelheim

  2. Virbac Group

  3. Elanco Inc.

  4. Merck & Co. Inc.

  5. Soparfin SCA (Vetiquinol)

  6. *Disclaimer: Major Players sorted in no particular order
Animal Hormone Therapy Market Concentration